United Therapeutics (UTHR) Operating Income (2009 - 2026)
United Therapeutics (UTHR) posted Operating Income of $325.8 million for Q1 2026, down 8.66% sequentially from $356.7 million in Q4 2025, and down 14.89% YoY from $382.8 million in Q1 2025.
United Therapeutics (UTHR) Operating Income (2009 - 2026) Analysis & Trends
United Therapeutics has reported Operating Income for 18 years, with the latest figure at $325.8 million in Q1 2026.
- Quarterly Operating Income fell 14.89% year-over-year to $325.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 2.28% YoY) and the FY2025 annual result came in at $1.5 billion, up 8.39% from the prior year.
- Operating Income fell to $325.8 million in Q1 2026 per UTHR's latest filing, from $356.7 million in the prior quarter.
- Over five years, Operating Income peaked at $388.5 million in Q3 2025 and troughed at $175.6 million in Q4 2022.
- A 5-year average of $315.3 million and a median of $325.8 million in 2026 frame the typical range for Operating Income.
- The sharpest annual moves came in 2022 and 2026: Operating Income soared 544.44% in 2022, then declined 14.89% in 2026.
- Over 5 years, Operating Income stood at $175.6 million in 2022, then surged by 48.12% to $260.1 million in 2023, then soared by 37.52% to $357.7 million in 2024, then declined by 0.28% to $356.7 million in 2025, then declined by 8.66% to $325.8 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered $325.8 million, $356.7 million, and $388.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | 18.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 330.80 Mn |
| Mar 31, 2026 | 325.80 Mn |
| Dec 31, 2025 | 356.70 Mn |
| Sep 30, 2025 | 388.50 Mn |
| Jun 30, 2025 | 364.50 Mn |
| Mar 31, 2025 | 382.80 Mn |
| Dec 31, 2024 | 357.70 Mn |
| Sep 30, 2024 | 343.10 Mn |
| Jun 30, 2024 | 319.90 Mn |
| Mar 31, 2024 | 356.30 Mn |
| Dec 31, 2023 | 260.10 Mn |
| Sep 30, 2023 | 327.00 Mn |
| Jun 30, 2023 | 313.40 Mn |
| Mar 31, 2023 | 284.40 Mn |
| Dec 31, 2022 | 175.60 Mn |
| Sep 30, 2022 | 314.30 Mn |
| Jun 30, 2022 | 201.80 Mn |
| Mar 31, 2022 | 288.00 Mn |
| Dec 31, 2021 | 169.80 Mn |
| Sep 30, 2021 | 228.70 Mn |